CANADA - 2025/05/29: In this photo illustration, the Tempus AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty ImagesGreat news for Tempus AI stock! The company has just received FDA approval for an upgraded version of its Tempus Pixel platform — a cardiac imaging system that uses advanced AI to deliver highly accurate images of a patient’s heart.Remember when we talked about TEM last month and how ...

Tempus AI (TEM) shares soared 13.6% in the last trading session to close at $88.78. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 12.3% gain over the past four weeks.Tempus AI recorded a strong price rise on investors’ optimism following the Food and Drug Administration (FDA) approval for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update allows the generation of T1 and T2 inline maps, further enhancin ...

We recently published 10 Stocks Investors Are Gobbling Up. Tempus AI, Inc. (NASDAQ:TEM) is one of the best performers on Thursday. Shares of Tempus AI surged to a seven-month high on Thursday, jumping 13.59 percent to close at $88.78 apiece as investors cheered the Food and Drug Administration’s (FDA) green light for the updated version of Tempus Pixel, its AI-powered cardiac imaging platform. During the session, the stock touched a high of $91.06, or just 39 cents shy of its 52-week high of $91.45. Tem ...

On Thursday, Cathie Wood-led Ark Invest executed significant trades involving Tempus AI Inc. (Pre-Reincorporation)TEM, Bullish BLSH, Amazon.com Inc. AMZN, and Figma Inc. FIG.The Tempus AI TradeArk Invest made a notable move by selling shares of Tempus AI across its ARK Genomic Revolution ETF ARKG and ARK Innovation ETF ARKK. The sale involved 8,864 shares in ARKG and 49,765 shares in ARKK. With a closing price of $88.78 on Thursday, the total value of the shares sold amounted to approximately $5.2 million. ...

Key Points The company was given a green light by an important regulator. Its updated heart imaging platform received clearance for commercialization. 10 stocks we like better than Tempus AI › The stock of healthcare-focused artificial intelligence company Tempus AI (NASDAQ: TEM) was the cure for aching portfolios on Thursday. The company's share price ballooned by almost 14% on the back of a top regulator's decision about one of its products. That price pop was much more muscular than the S&P 500 ...

On Thursday, Tempus AI, Inc. TEM received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform.The update allows the generation of T1 and T2 inline maps, further enhancing the device’s cardiac MR image analysis capabilities.Tempus Pixel provides advanced viewing and automated reporting of cardiac MR images, improving efficiency and accuracy in flow visualization, functional analysis, and tissue characterization.Also Read: Temp ...

BREAKING: Core CPI Steady, Jobless Claims Highest Since Oct. 2021Tempus AI (TEM) stock jumped into a profit-taking zone Thursday after the Food and Drug Administration cleared its updated cardiac-imaging platform, Tempus Pixel.The platform uses artificial intelligence to view cardiac magnetic resonance images, or MRI. Unlike conventional MR images that only show brightness differences, Tempus Pixel's maps provide precise numerical values to cardiac tissue characteristics. This helps clinicians detect condit ...